Product Pathways - Apoptosis
Siva-1 Antibody #12532
|12532S||100 µl (10 western blots)||---||In Stock||---|
|12532||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
Siva-1 Antibody recognizes endogenous levels of total Siva-1 protein. This antibody does not cross-react with Siva-2. This antibody cross-reacts with a protein of unknown origin at ~70 kDa.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro71 of human Siva-1 protein. Antibodies are purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from MOLT-4, HBP-ALL, and CCRF-CEM cells using Siva-1 Antibody.
Western blot analysis of extracts from 293T cells, mock transfected (-), transfected with a construct expressing Myc/DDK-tagged full-length human Siva-1 (hSiva-1-Myc/DDK; +), or transfected with a construct expressing Myc/DDK-tagged full-length human Siva-2 (hSiva-2-Myc/DDK; +), using Siva-1 Antibody or Myc-Tag (71D10) Rabbit mAb #2278.
Immunoprecipitation of Siva-1 from MOLT-4 cell extracts using Normal Rabbit IgG #2729 (lane 2) or Siva-1 Antibody (lane 3). Lane 1 is 10% input. Western blot analysis was performed using Siva-1 Antibody.
First identified as a pro-apoptotic protein that binds the cytoplasmic tail of the TNF receptor superfamily member CD27 (1), Siva-1 also binds several other TNFR family members including glucocorticoid-induced tumor necrosis factor receptor (GITR) and OX40 (1-3), as well as anti-apoptotic Bcl-2 family members Bcl-xL and Bcl-2 (4,5). Siva-1 is composed of a central death domain homology region, a C-terminal box-B-like ring finger followed by a zinc finger-like domain, and a unique N-terminal amphipathic helical region (SAH) (1,4). Studies have demonstrated that Siva-1 has the ability to induce cell death via both the extrinsic and intrinsic apoptotic pathways (1-8). The SAH domain of Siva-1 is responsible for the inhibition of the pro-survival activities of Bcl-xL and Bcl-2, leading to caspase-mediated cell death (4,5,8). Siva-1 plays a role in T cell signaling and homeostasis by inhibiting NF-κB activity, also resulting in apoptotic cell death (7,9). An alternative splice variant of Siva-1, Siva-2, lacks part of the SAH and death domains and is less effective at inducing apoptosis (1,2,5,8). Studies in xenografts have shown that down-regulation of Siva-1 inhibits tumorigenesis in response to p53 activation (10). Down-regulation of Siva-1 may also play a role in tumor metastasis through its regulation of the epithelial-mesenchymal transition (EMT) and cell migration (11). Overexpression of Siva-1 is implicated in several pathological conditions including acute ischemic injury (12) and Coxsackievirus infection (13).
- Prasad, K.V. et al. (1997) Proc Natl Acad Sci U S A 94, 6346-51.
- Yoon, Y. et al. (1999) Oncogene 18, 7174-9.
- Spinicelli, S. et al. (2002) Cell Death Differ 9, 1382-4.
- Xue, L. et al. (2002) Proc Natl Acad Sci U S A 99, 6925-30.
- Chu, F. et al. (2004) Apoptosis 9, 83-95.
- Cao, C. et al. (2001) J Biol Chem 276, 11465-8.
- Gudi, R. et al. (2006) Oncogene 25, 3458-62.
- Py, B. et al. (2004) J Immunol 172, 4008-17.
- Hench, V.K. and Su, L. (2011) BMC Immunol 12, 54.
- Du, W. et al. (2009) Cell Death Differ 16, 1493-504.
- Li, N. et al. (2011) Proc Natl Acad Sci U S A 108, 12851-6.
- Padanilam, B.J. et al. (1998) Kidney Int 54, 1967-75.
- Henke, A. et al. (2000) J Virol 74, 4284-90.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.